Scarica l'app Stockscreener
24.40
4.14%
0.97
Dopo l'orario di chiusura:
24.02
-0.38
-1.56%
Precedente Chiudi:
$23.43
Aprire:
$23.54
Volume 24 ore:
1.44M
Relative Volume:
0.64
Capitalizzazione di mercato:
$1.52B
Reddito:
$14.34M
Utile/perdita netta:
$-199.00M
Rapporto P/E:
-6.2245
EPS:
-3.92
Flusso di cassa netto:
$-183.51M
1 W Prestazione:
+9.07%
1M Prestazione:
+6.83%
6M Prestazione:
+59.17%
1 anno Prestazione:
+81.95%
Intervallo 1D:
$22.83
$24.65
Intervallo di 1 settimana:
$20.17
$24.98
Portata 52W:
$7.76
$71.50
Uniqure N V Stock (QURE) Company Profile
Nome
Uniqure N V
Settore
Industria
Telefono
1-339-970-7000
Indirizzo
PAASHEUVELWEG 25A, AMSTERDAM
Compare QURE vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QURE
Uniqure N V
|
24.40 | 1.46B | 14.34M | -199.00M | -183.51M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.27 | 119.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
782.38 | 83.75B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
847.26 | 52.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
339.37 | 44.12B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
354.48 | 39.73B | 4.98B | 69.60M | 525.67M | 0.5198 |
Uniqure N V Stock (QURE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-28 | Iniziato | Barclays | Equal Weight |
| 2025-11-04 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-08-14 | Aggiornamento | Mizuho | Neutral → Outperform |
| 2025-04-01 | Ripresa | Chardan Capital Markets | Buy |
| 2024-12-10 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-02-29 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-19 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-17 | Aggiornamento | UBS | Neutral → Buy |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-21 | Iniziato | UBS | Neutral |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-04-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2021-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-11-24 | Iniziato | H.C. Wainwright | Buy |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-11-09 | Iniziato | Jefferies | Buy |
| 2020-11-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-08-25 | Iniziato | Raymond James | Strong Buy |
| 2020-07-31 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-06-25 | Downgrade | Mizuho | Buy → Neutral |
| 2020-06-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-06-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2019-12-03 | Iniziato | Cowen | Outperform |
| 2019-12-03 | Iniziato | Goldman | Buy |
| 2019-11-05 | Iniziato | Credit Suisse | Outperform |
| 2019-10-11 | Iniziato | Stifel | Buy |
| 2019-09-25 | Iniziato | Bernstein | Outperform |
| 2019-09-12 | Iniziato | Mizuho | Buy |
| 2019-07-30 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-07-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2019-04-12 | Iniziato | Piper Jaffray | Overweight |
| 2019-03-29 | Iniziato | Robert W. Baird | Outperform |
Mostra tutto
Uniqure N V Borsa (QURE) Ultime notizie
uniQure Faces Securities Fraud Class Action After FDA Approval Delay - National Today
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming DeadlinesQURE - PR Newswire
QURE SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire
Levi & Korsinsky Reminds uniQure Investors of the Pending - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 13, 2026 in uniQure LawsuitQURE - PR Newswire
QURE INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds uniQure - GlobeNewswire
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of ... - Bluefield Daily Telegraph
UNIQURE N.V. (QURE) SHAREHOLDER ALERT Bernstein Liebhard - GlobeNewswire
Avoiding Lag: Real-Time Signals in (QURE) Movement - Stock Traders Daily
uniQure N.V. Sued for Securities Law ViolationsContact Levi & - GuruFocus
uniQure Shareholder Alert: ClaimsFiler Reminds Investors - GlobeNewswire
QURE: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against uniQure N.V. - Nasdaq
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact The ... - Bluefield Daily Telegraph
Class Action Filed Against uniQure N.V. (QURE) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Why uniQure (QURE) Is Down 12.0% After AMT-130 Lawsuits Challenge Its FDA Milestone Story - simplywall.st
UNIQURE N.V. (QURE) DEADLINE ALERT Bernstein Liebhard LLP Reminds uniQure N.V. Investors of Upcoming Deadline - ACCESS Newswire
uniQure investors face April 13 deadline for class action lawsuit By Investing.com - Investing.com India
QURE UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 - TMX Newsfile
uniQure (NASDAQ:QURE) Trading Up 6.6%Should You Buy? - MarketBeat
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - GlobeNewswire Inc.
FinancialContentINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE - FinancialContent
Class Action Announcement for uniQure N.V. Investors: Kessler Top - The National Law Review
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit – Company Announcement - Financial Times
Aug PreEarnings: Is uniQure NV affected by consumer sentimentGold Moves & Reliable Intraday Trade Plans - baoquankhu1.vn
UNIQURE N.V. (QURE) INVESTOR ALERT Investors With Large - GlobeNewswire
Holzer & Holzer, LLC Reminds QURE Investors of the April - GlobeNewswire
Class Action Lawsuit Filed Against uniQure N.V. - Intellectia AI
QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the ... - Caledonian Record
QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action - GlobeNewswire Inc.
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - bdtonline.com
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class ActionQURE - TMX Newsfile
Will uniQure N.V. benefit from green energy policiesEarnings Summary Report & Daily Profit Focused Stock Screening - mfd.ru
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
Can uniQure N.V. stock reach $100 price targetJuly 2025 Trade Ideas & High Accuracy Swing Entry Alerts - mfd.ru
Aberdeen Group plc Raises Stock Holdings in uniQure N.V. $QURE - MarketBeat
What is uniQure N.V.’s valuation compared to sectorInsider Buying & Technical Analysis for Trade Confirmation - mfd.ru
ROSEN, SKILLED INVESTOR COUNSEL, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class ActionQURE - TMX Newsfile
QURE Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against uniQure N.V. (QURE) - NewMediaWire
Is uniQure N.V. affected by consumer sentiment2025 Volatility Report & High Accuracy Swing Trade Signals - mfd.ru
uniqure investor lawsuit deadline set for April 13 following FDA setback By Investing.com - Investing.com Nigeria
Surprises Report: Will uniQure NV stock go up in YEARFed Meeting & Free Verified High Yield Trade Plans - baoquankhu1.vn
Will uniQure N.V. stock split again soonJuly 2025 Price Swings & Accurate Entry/Exit Alerts - mfd.ru
Robbins LLP Reminds Investors of Class Action Against uniQure N.V. - National Today
UniQure (QURE) Reports Positive Phase I/IIa AMT-191 Data for Fabry Disease, Shows Sustained Enzyme Activity - Finviz
Class Action Reminder for uniQure N.V. Shareholders - Intellectia AI
Class Action Lawsuit Announced for uniQure N.V. - Intellectia AI
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages uniQure N.V. - GlobeNewswire
Uniqure N V Azioni (QURE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):